Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib on Angiogenesis Markers in Operable Head and Neck Cancer
NCT00357617Phase 2Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in head and neck squamous cell carcinoma (HNSCC), sponsored by Lausanne University Hospital. Status: unknown.
02
Drugs
celecoxib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00357617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357617.